Contemporary status
Biocultural conservation and economies
Coca exists simultaneously in household gardens, Indigenous territories, legal regional markets, state purchasing systems, licensed pharmaceutical chains and illicit cocaine economies. These systems overlap geographically but are not interchangeable. Fresh and dried leaves, tea, flour, sweets, ritual bundles and medicines circulate legally within parts of Bolivia, Peru and Colombia; cocalero unions have become major political institutions. In the illicit chain, small cultivators usually receive a minor share of final value while armed control, interdiction, processing and transnational distribution capture the largest margins and generate violence and environmental damage (Gootenberg, 2008; UNODC, 2024).
Treaty returns illuminate a much narrower licit international channel. The INCB recorded national reports of 25,728 tonnes of coca leaf produced in Bolivia and 1,259.3 tonnes in Peru in 2024. Peru reported 150.3 tonnes exported, principally into the licensed United States flavouring and pharmaceutical stream. Different national reporting systems and the large informal market prevent these figures from serving as direct estimates of total traditional demand (INCB, 2026).
Total area is not a conservation proxy. Cultivated coca is not scarce, yet clonal ipadu, named local stocks and wild Erythroxylum relatives can be lost through displacement, eradication, commercial replacement and habitat conversion. The biocultural unit includes seed or cutting, soil knowledge, pruning, women’s processing labour, ritual vocabulary and the institutions through which leaves are exchanged. Conservation of that unit differs from maximising hectares (Plowman, 1981; Garcia Rodriguez, 2026).
Law and international scheduling
| United Nations | Coca leaf remains in Schedule I of the 1961 Single Convention. Article 49 originally required transitional abolition of coca chewing within twenty-five years. The 1988 Convention later required eradication measures to respect fundamental human rights and to take due account of traditional licit uses supported by historic evidence (United Nations, 1961; 1988). |
| WHO review, 2025 | Following Bolivia’s request and a two-year critical review, the WHO Expert Committee on Drug Dependence recommended no scheduling change in December 2025. It found that traditional chewing and tea did not pose major public-health risks, recognised cultural and therapeutic significance, but retained control because the leaf is convertible to cocaine and because evidence on dependence, long-term safety and therapeutic applications remained limited (WHO, 2025). |
| Bolivia | Bolivia denounced the Convention and re-acceded in 2013 with a reservation permitting traditional chewing and domestic traditional uses within its territory. Law No. 906 (2017) recognises coca as cultural patrimony and authorises up to 22,000 hectares divided principally between La Paz and Cochabamba production zones (Estado Plurinacional de Bolivia, 2017). |
| Peru | Traditional possession and use are legal within a state-controlled framework; the Empresa Nacional de la Coca (ENACO) holds the formal purchasing and commercial monopoly established under Decree Law No. 22095. A large parallel market and cultivation outside the registered system make the licit/illicit boundary politically and empirically contested (Republic of Peru, 1978). |
| Colombia | National drug law controls coca cultivation and cocaine production while Article 7 of Law 30 (1986), constitutional jurisprudence and Indigenous jurisdiction preserve space for ancestral use in recognised communities. The resulting dual status distinguishes cultural leaf practice from illicit commodity production but produces recurrent conflict over policing, food products and market access (Republic of Colombia, 1986). |
| United Kingdom / US | The United Kingdom lists coca leaf as a Class A, Schedule 1 controlled drug. In the United States coca leaves and cocaine are Schedule II, with a statutory exception for decocainised coca leaves or extracts; licensed medical and flavouring channels are narrow exceptions to general control (Home Office, 2025; eCFR, 2026). |
Cultivation metrics and environmental politics
UNODC estimated 253,000 hectares of coca cultivation in Colombia in 2023, ten per cent above 2022, and a 53% rise in potential cocaine production to 2,664 metric tonnes. These are monitoring categories for an illicit economy: they do not reliably identify botanical varieties, quantify traditional leaf markets or equate every plot with identical yield. Coca expansion can accompany deforestation and chemical contamination, yet regional forest loss also involves cattle, roads, land speculation, mining and armed governance. Forced eradication and aerial glyphosate have themselves damaged crops, displaced cultivation and intensified distrust. A botanical monograph must therefore keep plant ecology distinct from the political ecology of prohibition while analysing their contact (UNODC, 2024; White et al., 2025).
Patents and intellectual property
Extract processesPatents including US4956429A and US4696819A claim processes or compositions for reducing cocaine/ecgonine in coca flavour extracts or using water-soluble coca fractions; EP1688048A1 concerns a coca-leaf beverage/extract process. Such claims attach to methods and formulated products, not ownership of E. coca, coca leaves in nature or ancestral ritual systems.
Pharmaceutical cocainePatents around purified cocaine formulations, delivery devices and analytical standards belong to pharmaceutical or forensic innovation. They neither establish novelty in Indigenous leaf use nor collapse the pharmacology of those inventions into that of a quid or mambe.
Disclosure regimeThe 2024 WIPO Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge creates a disclosure requirement for patent inventions based on genetic resources or associated Indigenous knowledge once the treaty is in force for relevant parties. It is a patent-transparency mechanism, not a general grant of ownership, benefit sharing or retroactive invalidation (WIPO, 2024).
Latest research
2026Ritual knowledge under social fracture
Murui-Muinaɨ ethnography shows women and affinal kin creating new paths for coca–tobacco knowledge when violence and kinship disruption interrupt idealised male primogeniture (Garcia Rodriguez, 2026).
2025–26International review and human physiology
WHO completed the first coca-leaf critical review in decades and retained Schedule I while explicitly distinguishing low-risk traditional chewing and tea from cocaine production. A Peruvian observational study reported an association between habitual chewing and lower salivary cortisol among high-altitude miners (WHO, 2025; Lopez-Chau et al., 2026).
2025Coca–cocaine policy distinction
An interdisciplinary Science policy analysis joined taxonomy, pharmacology and cultural history to argue that the four cultivated cocas and traditional leaf practices require categories distinct from purified cocaine (White et al., 2025).
2024Leaf morphometrics and phylogenomics
Geometric morphometrics and DNA data refined identification across cultivated coca varieties while showing why leaves alone remain unreliable in archaeological and forensic classification (Przelomska et al., 2024).
2022Complete cocaine biosynthetic pathway
Yeast-based pathway discovery identified missing enzymes and reconstructed coca tropane-alkaloid biosynthesis, consolidating evidence for its independent evolution from Solanaceae pathways (Chavez et al., 2022).